The efficacy of subcutaneous sumatriptan in the treatment of recurrence of migraine headache

Journal of Neurology Neurosurgery and Psychiatry

Volumn 62, Issue 5, 1997, Pages 490-495

  Cull, R E ^a   Price, W H ^a   Dunbar, A ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Headache recurrence; Migraine; Sumatriptan; Tolerability

Indexed keywords

SUMATRIPTAN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FATIGUE; FEMALE; HEADACHE; HUMAN; INJECTION PAIN; MAJOR CLINICAL STUDY; MALAISE; MALE; MIGRAINE; MULTICENTER STUDY; NAUSEA; PARESTHESIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SUBCUTANEOUS DRUG ADMINISTRATION; VERTIGO; VOMITING;

EID: 0031008753     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.62.5.490     Document Type: Article

References (18)

1. Humphrey PPA, Fenuik W. Mode of action of the antimigraine drug sumatriptan. Trends Pharmacol Sci 1991; 12:444-6.
2. Hamel E, Fan E, Linville D, Ting V, Villemure J, Chia LS. Expression of mRNA for the serotonin 5-hydroxytryptamine 1 Db Receptor subtype in human and bovine cerebral arteries. Mol Pharmacol 1993;44:242-6.
3. Pilgrim AJ, Blakeborough P. The clinical efficacy of sumatriptan in the acute treatment of migraine. Reviews of Contemporary Pharmacotherapy 1994;5:295-309.
4. Simmons VE, Blakeborough P. The safety profile of sumatriptan in the acute treatment of migraine. Reviews of Contemporary Pharmacotherapy 1994;5:319-28.
5. Cady RK, Wendt JK, Kirchner JR, Sargent JD, Rothrock JF, et al. Treatment of acute migraine with subcutaneous sumatriptan. JAMA 1991;265:2831-5.
6. The Subcutaneous Sumatriptan International Study Group. Treatment of migraine attacks with sumatriptan. N Engl J Med 1991;325:316-21.
7. The Sumatriptan Auto-injector Study Group. Self-treatment of acute migraine with subcutaneous sumatriptan using an auto-injector device. Eur Neurol 1991;31: 323-31.
8. O'Callaghan J, for the Study Group. Long-term efficacy of subcutaneous sumatriptan using a novel self-injector. Cephalalgia 1993;13(suppl 13):161.
9. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 198;8(suppl 7):19-28.
10. Machin D, Campbell MJ. Statistical tables for the design of clinical trials. Oxford: Blackwell Scientific, 1987.
11. Cleland PG, Barnes D, Elrington GM, Schapira AHV. Does Pizotifen prophylaxis improve migraine beyond the benefit offered by sumatriptan therapy? Cephalalgia 1995; 15(suppl 14):263
12. Fowler PA, Lacey LF, Thomas M, Keene ON, Tanner RJN, Baber NS. The clinical pharmacology, pharmacokinetics and metabolism of sumatriptan. Eur Neurol 1991; 31:291-4.
13. Blau JN. Sumatriptan and the recurrence of migraine. Lancet 1992;340:1110.
14. Mathew NT. Drug-induced headache. Neurol Clin 1990; 8:903-12.
15. Mathew NT, Kurman R, Perez F. Drug-induced refractory headache - clinical features and management. Headache 1990;30:634-8.
16. Tansey MJB, Pilgrim AJ, Martin PM. Long-term experience with sumatriptan in the treatment of migraine. Eur Neurol 1993;33:310-5.
17. Catarci T, Fiacco F, Argentino C, Sette G, Cerbo R. Ergotamine-induced headache can be sustained by sumatriptan daily intake. Cephalalgia 1994;14:374-5.
18. Catarci T, Lenzi GL, Cerbo R, Fieschi C. Sumatriptan and daily headache. J Neurol Neurosurg Psychiatry 1995;58: 508.